Coverage
-
November 29, 2017
Reckitt Benckiser Inc. has reached a settlement with a generic-drug maker that had accused the British company of unfairly cutting out competition for an extended-release version of Mucinex by violating a patent infringement settlement agreement they'd struck, according to a judgment Tuesday ending the Pennsylvania federal court case.
4 other articles on this case.
View all »